SIAMAB THERAPEUTICS, INC.

Profile

Company Names

SIAMAB THERAPEUTICS, INC.
SIALIX, INC.
GC-FREE, INC.

Addresses

90 BRIDGE STREET, SUITE 100, NEWTON, MA 02458

48 WILDE ROAD, NEWTON, MA 02468

1396 POINSETTIA AVENUE, VISTA, CA 92081

Phone Numbers

800-513-1569
858-623-0276

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER

Year Incorporated:

2006

State Incorporated:

DELAWARE

Total Amount Raised:

$8,844,038.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2018-10-26 
$664,501.00 
$2,000,000.00 
$1,335,499.00 
Debt 
6
2015-03-30 
$3,213,332.00 
$7,000,000.00 
$3,786,668.00 
Equity 
5
2014-06-30 
$526,998.00 
$1,500,000.00 
$973,002.00 
Equity 
4
2013-07-15 
$2,464,207.00 
$2,522,569.00 
$58,362.00 
Equity 
3
2012-09-25 
$400,000.00 
$1,995,000.00 
$1,595,000.00 
Equity 
2
2011-07-29 
$875,000.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2010-03-10 
$700,000.00 
$700,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFFREY 
 
BEHRENS 
EXECUTIVE OFFICER, DIRECTOR
BRAD 
 
CURLEY 
DIRECTOR
MARK 
 
HATTENDORF 
DIRECTOR, EXECUTIVE OFFICER
ROBERT 
 
MASHAL 
DIRECTOR
GARY 
 
PFORZHEIMER 
DIRECTOR
AJIT 
 
VARKI 
DIRECTOR
NISSI 
 
VARKI 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-10-26 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-06-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-09-25 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-29 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#